Advanced search×

Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children.

S S Yehuda, S S Rabinovitz-Shenkar, and R L RL Carasso

Eur J Clin Nutr 65(10):1167-9 (2011) PMID 21587279

Inattention, hyperactivity and impulsivity constitute the core diagnostic criteria for attention deficit hyperactivity disorder (ADHD) children. Patients generally suffer from sleep disturbance and malnutrition that can account for tiredness during the day, poor concentration, poor eating and depressed mood, along with anemia and an n-3 polyunsaturated acid deficiency. The change of ADHD behavior in children (9-12) was studied, following 10 weeks of treatment with a polyunsaturated acid mixture on six variables: cooperation, mood, concentration, homework preparation, fatigue and sleep quality. Iron status was also examined. Polyunsaturated acid administration was associated with significant improvement in quality of life, ability to concentrate, sleep quality and hemoglobin levels.

DOI: 10.1038/ejcn.2011.80
Version: za2963e q8zaf q8zb8 q8zcf q8zd6 q8ze4 q8zf4 q8zg2

Similar articles you may find interesting…

  1. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine.
    L Eugene Arnold, Robert A Disilvestro, ... Elizabeth Joseph

    J Child Adolesc Psychopharmacol 21(1):1-19 (2011) PMID 21309695

    We randomly assigned 52 children aged 6-14 with DSM-IV ADHD to zinc supplementation (15 mg every morning [qAM] or two times per day [b.i.d.] as glycinate, n = 28) or matched placebo (n = 24) for 13 weeks: 8 weeks monotherapy and then 5 weeks with added d-amphetamine (AMPH). AMPH dose was w...
  2. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine.
    L Eugene Arnold, Robert A Disilvestro, ... Elizabeth Joseph

    J Child Adolesc Psychopharmacol 21(1):1-19 (2011) PMID 21309695

    We randomly assigned 52 children aged 6-14 with DSM-IV ADHD to zinc supplementation (15 mg every morning [qAM] or two times per day [b.i.d.] as glycinate, n = 28) or matched placebo (n = 24) for 13 weeks: 8 weeks monotherapy and then 5 weeks with added d-amphetamine (AMPH). AMPH dose was w...
  3. A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive functi...
    S H L SH Yi, J A JA Kable, ... R H RH Singh

    Prostaglandins Leukot Essent Fatty Acids 85(6):317-27 (2011) PMID 22000478

    Low blood docosahexaenoic acid (DHA) is reported in patients with phenylketonuria (PKU); however, the functional implications in adolescents and adults are unknown. This pilot study investigated the effect of supplemental DHA on cognitive performance in 33 females with PKU ages 12-47...